Utah Medical Products, Inc.

Equities

UTMD

US9174881089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
65.92 USD -0.56% Intraday chart for Utah Medical Products, Inc. -3.88% -21.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q1 Revenue $11.3M MT
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q1 EPS $1.09 MT
Utah Medical Products Keeps Quarterly Dividend at $0.30 Per Share, Payable on April 3 to Shareholders on March 15 MT
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Utah Medical Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Microsoft Kicks -2- DJ
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products Lifts Quarterly Dividend by 1.7% to $0.30 a Share, Payable Jan. 3 to Shareholders of Record as of Dec. 15 MT
Utah Medical Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
North American Morning Briefing : Yields Fall -2- DJ
Utah Medical Products Maintains Quarterly Dividend at $0.295/Share, Payable Oct. 3 to Shareholders of Record Sept. 15 MT
Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023 CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 Revenue $12.9M MT
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 EPS $1.15 MT
Utah Medical Products, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
North American Morning Briefing : Alphabet, -2- DJ
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products Maintains Quarterly Dividend at $0.295 a Share, Payable July 6 to Shareholders of Record on June 16 MT
Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023 CI
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q1 Revenue $12.5M MT
Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023 CI
Chart Utah Medical Products, Inc.
More charts
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
Related indices
More about the company
  1. Stock Market
  2. Equities
  3. UTMD Stock
  4. News Utah Medical Products, Inc.
  5. Utah Medical Products Maintains Quarterly Dividend at $0.295/Share, Payable Oct. 3 to Shareholders of Record Sept. 15